Ache Laboratorios Farmaceuticos SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ache Laboratorios Farmaceuticos SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011800
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ache Laboratorios Farmaceuticos SA (Ache) is a drug company that offers generic products. The company provides prescription, prescription free, generic, dermatological, dermocosmetic drugs, nutraceuticals and probiotic products. Its activities include research, development, production, distribution and commercialization of biotechnology medicines. Ache manufactures cephalosporin antibiotics and commercialization of functional foods. The company exports drugs Canada, Colombia, Peru, Ecuador, Chile, Bolivia, Cista Rica, Venezuela, Mexico, the US and Dominica Republic. It operates through its industrial plants located in Guarulhos, Sao Paulo and Anapolis, Brazil. Ache is headquartered in Guarulhos, Brazil.

Ache Laboratorios Farmaceuticos SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 10
BioGaia Enters Into Distribution Agreement With Ache Labs 11
Hypermarcas Enters Into Joint Venture With Ache Labs, EMS Participacoes And Uniao Quimica Farmaceutica 12
Licensing Agreements 13
Oxford Nutrascience Enters Into Licensing Agreement With Ache Laboratorios 13
Acquisition 14
Ache Laboratorios Farmaceuticos Acquires Nortis Pharma 14
Pfizer, Novartis And Abbott Labs Reportedly Plan To Bid For Ache Labs 15
Ache Laboratorios Farmaceuticos SA – Key Competitors 17
Ache Laboratorios Farmaceuticos SA – Key Employees 18
Ache Laboratorios Farmaceuticos SA – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Key Facts 2
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ache Laboratorios Farmaceuticos SA, Deals By Therapy Area, 2011 to YTD 2017 8
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 10
BioGaia Enters Into Distribution Agreement With Ache Labs 11
Hypermarcas Enters Into Joint Venture With Ache Labs, EMS Participacoes And Uniao Quimica Farmaceutica 12
Oxford Nutrascience Enters Into Licensing Agreement With Ache Laboratorios 13
Ache Laboratorios Farmaceuticos Acquires Nortis Pharma 14
Pfizer, Novartis And Abbott Labs Reportedly Plan To Bid For Ache Labs 15
Ache Laboratorios Farmaceuticos SA, Key Competitors 17
Ache Laboratorios Farmaceuticos SA, Key Employees 18
Ache Laboratorios Farmaceuticos SA, Subsidiaries 19
Ache Laboratorios Farmaceuticos SA, Joint Venture 19

★海外企業調査レポート[Ache Laboratorios Farmaceuticos SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Allot Communications Ltd. (ALLT):企業の財務・戦略的SWOT分析
    Allot Communications Ltd. (ALLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Computershare Limited (CPU):企業の財務・戦略的SWOT分析
    Computershare Limited (CPU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Bear Creek Mining Corp (BCM):企業の財務・戦略的SWOT分析
    Summary Bear Creek Mining Corp (Bear Creek) is a silver exploration and development company. The company's projects include Santa Ana project and Corani project. Its Corani project located in the Andes Mountains of Peru and explores for silver, lead, zinc deposit. Bear Creek also conducts silver and …
  • British Columbia Cancer Agency-製薬・医療分野:企業M&A・提携分析
    Summary British Columbia Cancer Agency (BC Cancer Agency), a subsidiary of Provincial Health Services Authority is a healthcare service center that provides comprehensive cancer control program. The center offers services such as patient assessment, diagnostic and therapy planning, radiation therapy …
  • Andhra Petrochemicals Ltd (500012):企業の財務・戦略的SWOT分析
    Andhra Petrochemicals Ltd (500012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Cook Medical Inc:企業の戦略的SWOT分析
    Cook Medical Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Advance Syntex Ltd:企業の戦略的SWOT分析
    Advance Syntex Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Murphy Oil Corporation:戦略・SWOT・企業財務分析
    Murphy Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Murphy Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Electricity & Water Authority:企業の戦略的SWOT分析
    Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Resverlogix Corp (RVX)-製薬・医療分野:企業M&A・提携分析
    Summary Resverlogix Corp (Resverlogix) is an epigenetics company that develops small molecule therapeutics for Bromodomain and ExtraTerminal Domain (BET) inhibition. The company provides lead product such as RVX-208 (apabetalone), is a BET inhibitor under phase III clinical trial. Its RVX-208 is bei …
  • Kiadis Pharma NV (KDS):企業の財務・戦略的SWOT分析
    Summary Kiadis Pharma NV (Kiadis) is a biopharmaceutical company that develops and markets cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company offers cellular products including ATIR101 and ATIR201 for infusion. Its ATIR101 lowers the risks …
  • Nippon Shinyaku Co Ltd (4516):製薬・医療:M&Aディール及び事業提携情報
    Summary Nippon Shinyaku Co Ltd (Nippon) is a pharmaceutical company that develops, manufactures and sells ethical pharmaceuticals and functional foods. The company offers a wide range of products including drugs for pain, inflammation, and allergies; urological diseases; hematologic malignancies; ga …
  • Spire, Inc.:戦略・SWOT・企業財務分析
    Spire, Inc. - Strategy, SWOT and Corporate Finance Report Summary Spire, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Conatus Pharmaceuticals Inc (CNAT):製薬・医療:M&Aディール及び事業提携情報
    Summary Conatus Pharmaceuticals Inc (Conatus) is a biotechnology company that develops and commercializes novel medicines for the treatment of liver diseases. The company’s lead pipeline candidate includes emricasan, an orally active pan-caspase protease inhibitor which is designed to reduce the act …
  • Territorial Generation Company No. 11:企業の戦略的SWOT分析
    Territorial Generation Company No. 11 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Enterprise Products Partners LP (EPD)-エネルギー分野:企業M&A・提携分析
    Summary Enterprise Products Partners L.P. (Enterprise Products) is a provider of midstream energy services. The company‘s integrated midstream operations include natural gas gathering, treating, processing, transportation and storage; natural gas liquid transportation, fractionation, storage, and im …
  • Brunei LNG Sdn Bhd:企業の戦略的SWOT分析
    Brunei LNG Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Weifang Changan Steel Tower Stock Co Ltd:企業の戦略的SWOT分析
    Weifang Changan Steel Tower Stock Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Karus Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Karus Therapeutics Ltd (Karus) is a designer and developer of molecule cancer therapies. The company provides treatment of a diverse range of solid and hematological cancers and small molecule drug. It develops two clinic-tracked programs potent and selective inhibitors of PI3K and HDAC for …
  • WNDM Medical Inc (WNDM):医療機器:M&Aディール及び事業提携情報
    Summary WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone blee …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆